Our News

Link Biologics strengthens IP position for Link_TSG6 with US patent Notice of Allowance and University of Manchester IP assignment

London, UK - 05 May 2026

Link Biologics strengthens Board with drug discovery expert Dr Niall Martin to advance its TSG-6-based therapeutic pipeline

London, UK – 24 February 2026

Promising novel treatment for Dry Eye Disease revealed by new research

Manchester, UK - 02 September 2025

Promising novel treatment for Osteoarthritis revealed by new research

Manchester, UK - 02 September 2025

Link Biologics founder Tony Day elected to Academy of Medical Sciences

London, UK - 08 March 2025